Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Mira Y. Gökyildirim, Ulrich Grandel, Katja Hattar, Gabriele Dahlem, Elena Schuetz, Florian H. Leinberger, Fabian Eberle, Ulf Sibelius, Friedrich Grimminger, Werner Seeger, Rita Engenhart-Cabillic, Ekkehard Dikomey, Florentine S.B. Subtil
Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28976-28988
Ewa Rupniewska, Rajat Roy, Francesco A. Mauri, Xinxue Liu, Maciej Kaliszczak, Guido Bellezza, Lucio Cagini, Mattia Barbareschi, Stefano Ferrero, Anna M. Tommasi, Eric Aboagye, Michael J. Seckl, Olivier E. Pardo
Published Jun 8, 2018 · Vol. 9, No. 44 · pp. 27346-27362
Verena Rolfes, Christian Idel, Ralph Pries, Kirstin Plötze-Martin, Jens Habermann, Timo Gemoll, Sabine Bohnet, Eicke Latz, Julika Ribbat-Idel, Bernardo S. Franklin, Barbara Wollenberg
Published Jun 8, 2018 · Vol. 9, No. 44 · pp. 27460-27470